US Navy Grapples With Designer Drugs

.

US Navy Grapples With Designer Drugs

A recent report talked about how the US navy is trying to prevent its sailors from turning into sea monsters. They have revealed a video which features how one suffers from hallucination after taking designer drugs, "bath salts" or "spice", which induces effects of cocaine and methamphetamine.

It has left a strong impact on the military which has from the last one year, chucked out some 90 sailors from two San Diego ships. "I cannot emphasize enough to our Sailors and Marines that using synthetic drugs really is just like playing Russian roulette with their health, not to mention their career", said Vice Admiral Matthew L. Nathan, a US Navy surgeon general.

The video has featured how a sailor after taking the drug suffers from vomiting and even shows violent demonic hallucinations. Well he didn't stop there, he went on to attack his girlfriend and later pass out after suffering from seizures.

Earlier, the same designer drug was found responsible for the case surrounding the suicide of a St. Tammany, LA man, who had gulped down a packet of Cloud 9 'bath salts' before he committed suicide by slitting his throat in January 2011. The U. S. Navy is very much determined to scare the sailors so that they can save themselves from becoming the victims of such designer drugs.


Latest News

Although Scientists say GMOs are Safe to Eat But it is Not Easy to Convince Ever
Central States Pension Fund has No New Recovery Plan Seeks Legislation to Protec
Does Fewer Opioid Prescriptions in the U.S Reflect a Curb in the Wave of Addicti
Japan’s Exports Drop further in April adding to a Gloomy Outlook
The Long Drawn Battle for Control Over Sumner Redstone’s Trust Takes New Turn
April Payrolls Reflect Significant Increases in Eleven US States
Bids for Yahoo may Not Match Earlier Expectations
Tribune Publishing and Garnet Company Carry on with Takeover Battle
Oregon Governor asks glass firm to halt production amid pollution concerns
G7 finance ministers to meet on Friday
Bayer AG makes unsolicited offer for Monsanto